SCHEMBL4456955

SCHEMBL4456955

COc1ccc(C(=O)c2ccc(F)cc2)c(F)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.59
MAPT P10636 4/20 0.57
HTT P42858 3/20 0.57
NPSR1 Q6W5P4 1/20 0.57
CPS1 P31327 6/20 0.55
ALDH1A1 P00352 2/20 0.53
LMNA P02545 2/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
PGR P06401 1/20 0.53
CYP2D6 P10635 1/20 0.53
HPGD P15428 1/20 0.53
SLC6A2 P23975 1/20 0.53
PDE4A P27815 1/20 0.53
MAPK1 P28482 1/20 0.53
HRH1 P35367 1/20 0.53
SLC6A3 Q01959 1/20 0.53
PDE4D Q08499 1/20 0.53
RAB9A P51151 5/20 0.52
KMT2A Q03164 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5371452 0.90 NPC1 (0.59) NPC1MAPTHTTNPSR1CPS1
SCHEMBL4479518 0.88 POLB (0.67) NPC1MAPTHTTNPSR1CPS1
SCHEMBL3469063 0.88 KMT2A (0.63) NPC1MAPTHTTNPSR1CPS1
SCHEMBL20157807 0.87 NPC1 (0.59) NPC1MAPTHTTNPSR1ALDH1A1
SCHEMBL27467361 0.87 ALDH1A1 (0.69) NPC1MAPTHTTNPSR1CPS1
SCHEMBL6311417 0.86 KDM4E (0.58) NPC1MAPTHTTNPSR1CPS1
SCHEMBL3638432 0.86 HPGD (0.72) NPC1MAPTHTTNPSR1ALDH1A1
SCHEMBL3642302 0.86 NPC1 (0.82) NPC1MAPTHTTNPSR1ALDH1A1
SCHEMBL20157317 0.86 NPC1 (0.58) NPC1MAPTHTTNPSR1ALDH1A1
SCHEMBL29869422 0.86 NPC1 (0.82) NPC1MAPTHTTNPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576088-B2 Benzodioxole derivatives HOFFMAN-LA ROCHE INC. (US) 2009-08-18 US disclosed
EP-1532132-B1 NOVEL BENZODIOXOLES HOFFMANN LA ROCHE (CH) 2008-03-19 EP disclosed
US-20050143373-A1 Benzodioxole derivatives ALANINE ALEXANDER (FR) 2005-06-30 US disclosed
US-6900227-B2 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. (US) 2005-05-31 US disclosed
EP-1532132-A1 NOVEL BENZODIOXOLES F.HOFFMANN-LA ROCHE AG (CH) 2005-05-25 EP disclosed
US-20040142922-A1 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. 2004-07-22 US disclosed
WO-2004013120-A1 NOVEL BENZODIOXOLES F. HOFFMANN-LA ROCHE AG (CH) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143373-A1 Benzodioxole derivatives CNR2, CNR1, GPR119 NPC1 961/4885MAPT 4230/4885HTT 3224/4885
US-20040142922-A1 Benzodioxole derivatives CNR1, CNR2, GPR119 NPC1 519/4885MAPT 4527/4885HTT 3764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.